US at a glance
- Population
- 341.8 million 2025
- Life expectancy at birth
- 78.9 years, 2024
- People aged 65 and over
- 18.4 % of people, 2025
- Health spending per person
- 13,473 US$ per person, 2023
- Doctors
- 3.68 per 1,000 people, 2022
Updated
Reviewed by Vidhi Upadhyay
US AI in Clinical Trials Market Industry Trends and Forecast to 2034: Segmented by (Application, Phase, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$5.04 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $820.6 Mn | — | — |
| 2025 (base) | $1.00 Bn | +$181.4 Mn | — |
| 2026 (forecast) | $1.22 Bn | +$221.4 Mn | +22.1% |
| 2027 (forecast) | $1.49 Bn | +$270.4 Mn | +49.1% |
| 2028 (forecast) | $1.82 Bn | +$330.1 Mn | +82% |
| 2029 (forecast) | $2.23 Bn | +$403.1 Mn | +122.3% |
| 2030 (forecast) | $2.72 Bn | +$492.2 Mn | +171.4% |
| 2031 (forecast) | $3.32 Bn | +$600.9 Mn | +231.4% |
| 2032 (forecast) | $4.05 Bn | +$733.8 Mn | +304.6% |
| 2033 (forecast) | $4.95 Bn | +$895.9 Mn | +394% |
| 2034 (forecast) | $6.04 Bn | +$1.09 Bn | +503.2% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $1.00 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $6.04 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 22.1% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Application, phase and end user (see all) |
| Key players | IQVIA, Medidata (Dassault Systemes), Unlearn.AI, Deep 6 AI, Saama Technologies (see all) |
| Regulator in the US | FDASource: US Food and Drug Administration. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
AI in clinical trials helps design studies, find suitable patients, choose sites and analyse results faster.
Key segments of the AI in Clinical Trials market include application (Patient Recruitment, Trial Design and Site Selection) and phase (Phase I, Phase II and Phase III).
Advances in machine learning and large language models, more digital health data, clinician shortages and pressure to cut costs are driving the AI in Clinical Trials market. Health systems are moving from pilots to wider use.
Generative AI, automation of paperwork and AI tools approved as medical devices give the AI in Clinical Trials market strong growth, including in emerging health systems.
Concerns about accuracy, bias, privacy and liability, along with unclear regulation and the cost of fitting AI into clinical workflows, hold back the AI in Clinical Trials market.
The AI in Clinical Trials market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
The FDA regulates software that works as a medical device, and runs a Digital Health Center of Excellence.[1] Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).[2]
[1] US Food and Drug Administration. Checked 14 Nov 2026.
[2] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the AI in Clinical Trials market. Government digital health programs in the US are speeding up adoption.
What doctors and scientists are doing in AI in Clinical Trials right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 20 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 19 Nov 2026.
From our blog
US · 1 shared keyword
US
US
US
US
US
Pharmaceuticals · US
Healthcare Services · US
Healthcare Services · US
Healthcare Services · US
Healthcare Services · US
Healthcare Services · US